Drug Topics
JUNE 21, 2023
Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
Pharmacy Times
JUNE 20, 2023
A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 23, 2023
Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease. The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients.
Pharmaceutical Technology
JUNE 20, 2023
The World Health Organisation (WHO) has granted an emergency use listing (EUL) to SK bioscience’s Covid-19 vaccine, SKYCovione. SKYCovione is a self-assembled nanoparticle vaccine and the 12th Covid-19 vaccine to receive a EUL from the regulator. Developed using pharmaceutical company GSK’s pandemic adjuvant, the vaccine targets the receptor-binding domain of the SARS-CoV-2 spike protein.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JUNE 23, 2023
The Protect Patient Access to Pharmacies Act will help to secure Medicare patients’ freedom to receive medications and care from the pharmacy of their choice.
Pharmacy Times
JUNE 22, 2023
Treatment with lisocabtagene maraleucel led to strong and durable response rates with little serious adverse effects in patients with relapsed or refractory follicular lymphoma and mantle cell lymphoma.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JUNE 22, 2023
Physician-owned general acute care hospitals charge less than other non-physician-owned facilities in their region for several common shoppable care services, according to a new analysis published | A new analysis of competing hospitals' published prices adds fuel to the debate over whether Congress should lift the Affordable Care Act's ban on new physician-owned hospitals.
Drug Topics
JUNE 22, 2023
The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.
Pharmacy Times
JUNE 21, 2023
Antibiotics that were found to be most commonly associated with clostridium difficile infection are piperacillin/tazobactam, meropenem, vancomycin, ciprofloxacin, ceftriaxone, and levofloxacin, according to a recent study.
Fierce Pharma
JUNE 22, 2023
Even after second application attempt, Intercept’s Ocaliva wasn’t the fatty liver disease breakthrough that the company had hoped it would be. | Even after second application attempt, Intercept’s Ocaliva wasn’t the fatty liver disease breakthrough that the company had hoped it would be. Intercept is now swinging into restructuring mode, and the NASH baton passes on to Madrigal Pharma.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JUNE 21, 2023
For years, public health guidance about opioid overdoses has been relatively simple: Administer naloxone , then call 911. But the days of simply spraying naloxone into an overdose victim’s nose, then watching that person resume breathing and wake up within minutes, are over.
Drug Topics
JUNE 22, 2023
A study found that pharmacists possessed moderate to low knowledge scores when it came to statements tackling biosimilars.
Pharmacy Times
JUNE 20, 2023
Standard prediction models that assess an individual’s risk of developing dementia and how to prevent it are limited in their ability to do so, showing high error rates and a higher chance of receiving a false-positive result, according to a recent study.
Fierce Healthcare
JUNE 21, 2023
A pair of new reports released this week allege that HCA Healthcare policies are encouraging staff to transition more patients to palliative and end-of-life care, thereby increasing churn and boost | Two reports, one based on dozens of employee interviews and the other on policies and discharge statistics, paint a picture of internal policies encouraging transfers to boost quality metrics and free up hospital beds.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JUNE 21, 2023
Last year, after a string of high-profile trial failures , the Huntington’s disease community got positive news in the form of very early data from an experimental gene therapy for the rare neurodegenerative condition. On Wednesday, however, the company behind the drug released updated figures that were more mixed — even befuddling. The study from Uniqure, a Dutch biotech, randomized early stage Huntington’s patients to receive low-dose treatment, a high-dose treatment, or a
Drug Topics
JUNE 20, 2023
A recent review evaluated possible approaches for new vaccines targeting respiratory viruses.
Pharmacy Times
JUNE 21, 2023
Among health care professionals, pharmacists are best suited to serve as trusted partners for patients to help ensure they understand their medication regimen, identify medication-related problems, and work with prescribers to close gaps in care.
Fierce Pharma
JUNE 20, 2023
Used by Egyptians 35 centuries ago as a remedy for inflammation, colchicine was found over the ages to be effective against a variety of maladies including gout, dropsy and familial Mediterranean f | Agepha Pharma, a family-owned company based in Slovakia, has gained an FDA approval for Lodoco, which becomes the first drug to target cardiovascular inflammation.
STAT
JUNE 22, 2023
When I was diagnosed with Duchenne muscular dystrophy 20 years ago, there was no hope. The guidance the diagnosing doctor gave my parents was simple: Love your child as much as you can now because he won’t be here very long. That was the inspiration that my mom needed to start CureDuchenne. Her intention — our whole family’s intention — was to cure this disease so no other parents would have to go through the same traumatic prognosis.
Drug Topics
JUNE 21, 2023
Beauty and household items topped the list of what customers want to buy in the pharmacy.
Pharmacy Times
JUNE 22, 2023
CDC Advisory Committee on Immunization Practices recommends the use of respiratory syncytial virus (RSV) vaccine, adjuvanted (Arexvy) for adults 60 years of age and older based on findings from the first season of the pivotal AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial.
Fierce Healthcare
JUNE 21, 2023
Even in the face of substantial headwinds, dealmaking in the healthcare industry hasn't fallen off, according to a new analysis from PwC. | Even in the face of substantial headwinds, dealmaking in the healthcare industry hasn't fallen off, according to a new analysis from PwC.
Fierce Pharma
JUNE 20, 2023
After Merck filed a bombshell lawsuit challenging some measures in the Inflation Reduction Act (IRA), Bristol Myers Squibb has followed on with a case of its own. | After Merck took the first legal stab at the Inflation Reduction Act with a lawsuit against the Department of Health and Human Services (HHS), Bristol Myers Squibb is the latest drugmaker to allege Constitutional violations.
Drug Topics
JUNE 21, 2023
The first RSV vaccines were approved by the FDA earlier this year.
Pharmacy Times
JUNE 19, 2023
Liam Volk, MPharm, president-elect of the Pharmacists’ Defence Association LGBT+ Network, discussed how pharmacists can best support their LGBTQ+ colleagues and patients.
Fierce Healthcare
JUNE 22, 2023
Ochsner Health and The University of Texas MD Anderson Cancer Center are partnering to build an integrated cancer care program in southeastern Louisiana, the organizations announced Thursday. | The first phase of the new collaboration will see cancer patients at seven of Ochsner's southeast Louisiana facilities become eligible for breaking clinical trials.
Fierce Pharma
JUNE 22, 2023
The EMA is scrutinizing GLP-1s, raising a safety signal about the risk that drugs from Novo Nordisk, Eli Lilly and other companies could cause cancer.
European Pharmaceutical Review
JUNE 21, 2023
The US Food and Drug Administration (FDA) has approved LODOCO ® , the “first drug to target cardiovascular inflammation,” reported Dr Paul Ridker, MPH, Professor of medicine at Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital. It is the first anti-inflammatory cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adults with establ
Pharmacy Times
JUNE 22, 2023
The Act4Biosimilars Action Plan highlights major challengers in preventing access to biosimilars and actionable steps to accelerate the adoption by overcoming these challenges.
Fierce Healthcare
JUNE 23, 2023
Amazon Web Services launched a new innovation center focused on generative AI backed by a $100 million investment, its most recent bid to keep up with the AI race. | Amazon's cloud unit launched the AWS Generative AI Innovation Center with a $100 million investment, its most recent bid to keep up with the AI race.
Fierce Pharma
JUNE 22, 2023
The Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) has recommended that adults 60 and older—in consultation with their doctors—receive vacc | The CDC's Advisory Committee on Immunization Practices has recommended that adults 60 and older—in consultation with their doctors—receive vaccines to prevent lower respiratory tract disease caused by respiratory syncytial virus.
STAT
JUNE 23, 2023
GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such case that was about to go to trial in the U.S. In a brief statement , the company disclosed that it reached a settlement with James Goetz, who filed a lawsuit in a California state court. The deal reflected its desire “to avoid distraction related to protracted litigation in this case.
Pharmacy Times
JUNE 22, 2023
Christina Madison, PharmD, FCCP, AAHIVP, sat down with Sandra Leal, PharmD, MPH, FAPhA, CDCES, vice president of pharmacy practice innovation and advocacy at CVS Pharmacy, to discuss how pharmacists are diving into public health and expanding their roles.
Fierce Healthcare
JUNE 21, 2023
The southeastern region of the U.S. | The southeastern region of the U.S. scored worst across the board in the Commonwealth Fund’s annual scorecard on states' healthcare system performance.
Expert insights. Personalized for you.
183 
Let's personalize your content